Ep. 7 Tissue Engineering Career Conversations featuring Dr. Carlo Rizzuto, Managing Director at Versant Ventures
Description
Our seventh episode features Dr. Carlo Rizzuto, Managing Director at Versant Ventures. He joined the firm as a Principal in 2012 and has been promoted to Managing Director in 2022, where he is still involved in building and investing in a number of Versant’s portfolio companies. Prior to Versant Ventures, Dr. Rizzuto was at Novartis where he led global product development teams advancing innovative new medicine, and was an Associate Principal at McKinsey & Co. advising U.S. and European clients in the pharmaceutical, payor, and provider sectors. Dr. Rizzuto holds a Ph.D. in virology from Harvard University.
In this episode we discuss with Dr. Rizzuto his career journey, highlighting the several skills and tools he honed along the way. We learn which skills are essential to be a good investor and founder, how to manage an intensive schedule with long days, and how outstanding technology can be transferred from an academic bench to a biotechnology startup.
Versant Ventures is a venture capital company focused on biotech startups. This firm has a broad, diverse portfolio with successful stories of investment in biotech startups in the US, Canada, and Europe, in gene therapy, gene editing, cell therapy, and precision oncology.
United States
